Last reviewed · How we verify

NCT06755528

Effect of Shockwaves on Fallopian Tubes Adhesion

Not yet recruiting NA Last updated 7 January 2025
What this trial tests

NA trial testing Chitosan in Fallopian Tube Adhesion in 40 participants. Not yet recruiting.

Timeline
30 December 2024
Primary endpoint
28 February 2025
7 March 2025

Quick facts

Lead sponsorCairo University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date30 December 2024
Primary completion28 February 2025
Estimated completion7 March 2025

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 25 to 35, female only, with Fallopian Tube Adhesion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the effect of shock waves on fallopian tube adhesions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Chitosan

Trials testing the same drug.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06755528.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing